FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $502,000 | -51.5% | 13,334 | -78.1% | 0.00% | -50.0% |
| Q4 2020 | $1,036,000 | -0.4% | 60,892 | -72.5% | 0.00% | 0.0% |
| Q3 2020 | $1,040,000 | -51.4% | 221,377 | -36.9% | 0.00% | -33.3% |
| Q2 2020 | $2,141,000 | +131.7% | 350,930 | -13.8% | 0.00% | +50.0% |
| Q1 2020 | $924,000 | -55.2% | 407,242 | -9.4% | 0.00% | 0.0% |
| Q4 2019 | $2,063,000 | +287.1% | 449,403 | +226.7% | 0.00% | +100.0% |
| Q3 2019 | $533,000 | +20.0% | 137,571 | +579.2% | 0.00% | – |
| Q4 2017 | $444,000 | +8.8% | 20,255 | +103.2% | 0.00% | – |
| Q3 2017 | $408,000 | +99.0% | 9,968 | +46.5% | 0.00% | – |
| Q2 2017 | $205,000 | -90.5% | 6,802 | -88.7% | 0.00% | -100.0% |
| Q1 2017 | $2,168,000 | -66.2% | 59,952 | -53.2% | 0.00% | -66.7% |
| Q4 2016 | $6,419,000 | -33.1% | 128,095 | -30.0% | 0.01% | -40.0% |
| Q3 2016 | $9,601,000 | +93.3% | 182,908 | +52.3% | 0.02% | +66.7% |
| Q2 2016 | $4,967,000 | +138.9% | 120,122 | +134.7% | 0.01% | +125.0% |
| Q1 2016 | $2,079,000 | -42.1% | 51,179 | -40.8% | 0.00% | -33.3% |
| Q4 2015 | $3,589,000 | +78.7% | 86,483 | -33.7% | 0.01% | +50.0% |
| Q3 2015 | $2,008,000 | -51.7% | 130,448 | -22.1% | 0.00% | -50.0% |
| Q2 2015 | $4,158,000 | +99.5% | 167,378 | +83.5% | 0.01% | +60.0% |
| Q1 2015 | $2,084,000 | – | 91,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|